Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism-Reference-Cited by-同舟云学术

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

Published:2017-01-10 Issue: Volume: Page:cvw246
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:Cardiovasc Res

Author:

Valle Raleigh Juan,Mauro Adolfo G.,Devarakonda Teja,Marchetti Carlo,He Jun,Kim Erica,Filippone Scott,Das Anindita,Toldo Stefano,Abbate Antonio,Salloum Fadi N.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Reference43 articles.

1. Heart Disease and Stroke Statistics—2015 Update

2. Myocardial Reperfusion Injury

3. The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR)

4. Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program

5. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist;Molecular Pharmaceutics;2024-08-12

2. mir-605-3p prevents liver premetastatic niche formation by inhibiting angiogenesis via decreasing exosomal nos3 release in gastric cancer;Cancer Cell International;2024-05-27

3. Serelaxin Protects H9c2 Cardiac Myoblasts against Hypoxia and Reoxygenation-Induced Damage through Activation of AMP Kinase/Sirtuin1: Further Insight into the Molecular Mechanisms of the Cardioprotection of This Hormone;Antioxidants;2024-01-27

4. Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives;Clinical Research in Cardiology;2023-09-18

5. Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway;Chinese Journal of Integrative Medicine;2023-08-23